Henry Peter Beugelsdijk, MD in Newton, KS - Anesthesiology

Henry Peter Beugelsdijk, MD is a Anesthesiology - Pain Medicine physician based in Newton, Kansas. Henry Peter Beugelsdijk is licensed to practice in Kansas (license number 0416967) and his current practice location is 600 Medical Center Dr, Newton, Kansas. He can be reached at his office (for appointments etc.) via phone at (316) 283-2700.

NPI number for Henry Peter Beugelsdijk is 1164496428 and his current mailing address is Po Box 388, Newton, Kansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1164496428.

Contact Information

	Henry Peter Beugelsdijk, MD
	600 Medical Center Dr, Newton, KS 67114-8780
	(316) 283-2700
	Not Available

Physician's Profile

Full Name	Henry Peter Beugelsdijk
Gender	Male
Speciality	Anesthesiology - Pain Medicine
Location	600 Medical Center Dr, Newton, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1164496428
Provider Enumeration Date: 02/14/2006
Last Update Date: 05/12/2011

Medical Identifiers

Medical identifiers for Henry Peter Beugelsdijk such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1164496428	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207LP2900X	Anesthesiology - Pain Medicine	0416967 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Henry Peter Beugelsdijk is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Henry Peter Beugelsdijk, MD Po Box 388, Newton, KS 67114-0388 Ph: (316) 281-3700	Henry Peter Beugelsdijk, MD 600 Medical Center Dr, Newton, KS 67114-8780 Ph: (316) 283-2700

News Archive

Inovio Biomedical expands existing license agreement with the University of Pennsylvania

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that it has expanded its existing license agreement with the University of Pennsylvania, adding exclusive worldwide licenses for technology and intellectual property for novel DNA vaccines against pandemic influenza, Chikungunya, and foot-and-mouth disease.

Bristol-Myers Squibb launches Daklinza in the UK for treatment of chronic hepatitis C

Bristol-Myers Squibb today announced the launch of Daklinza▼ (daclatasvir) in the UK, a new medicine for the treatment of adult patients with chronic hepatitis C. Daclatasvir, a treatment that works across multiple hepatitis C genotypes, will allow up to 90% of UK patients the option of a potentially curative oral treatment regimen that does not include interferon, a standard of care commonly associated with sustained flu-like side effects.

Researchers develop new high-tech device for transferring DNA into cells

The ability to transfer a gene or DNA sequence from one animal into the genome of another plays a critical role in a wide range of medical research-including cancer, Alzheimer's disease, and diabetes.

ANTIPAF trial reveals ARBs do not reduce number of AF episodes in paroxysmal AF patients

Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting about 7 million people in Europe. It is a progressive chronic disease in which episodes become more frequent and long-lasting over time. Conventional anti-arrhythmic therapy aims at halting progression and reducing symptoms, but the use of most anti-arrhythmic drugs is compromised by severe side effects, such as pro-arrhythmia or extra-cardiac organ toxicity.

Henry Peter Beugelsdijk, MD - Anesthesiology in Newton, KS